Song Je Eun, Kwak Yee Gyung, Oh Gang-Bok, Choi Young Hwa, Kim Sung Ran, Han Su Ha, Yoo So-Yeon, Yoo Hyeon Mi, Choi Ji-Youn, Shin Myoung Jin
Department of Internal Medicine, Inje University Ilsan Paik Hospital, Goyang, Republic of Korea; Infection Control Office, Inje University Ilsan Paik Hospital, Goyang, Republic of Korea.
Department of Internal Medicine, Inje University Ilsan Paik Hospital, Goyang, Republic of Korea; Infection Control Office, Inje University Ilsan Paik Hospital, Goyang, Republic of Korea.
Am J Infect Control. 2024 Feb;52(2):214-219. doi: 10.1016/j.ajic.2023.06.020. Epub 2023 Jul 3.
This study analyzed the validity of healthcare-associated infection (HAI) data of the Korean National healthcare-associated Infections Surveillance System.
The validation process consisted of external (EV) and internal (IV) validation phases. Of the 193 hospitals that participated from July 2016 through June 2017, EV was performed for 10 hospitals that were selected based on the HAI rate percentile. The EV team reviewed 295 medical records for 60 HAIs and 235 non-HAI control patients. IV was performed for both the 10 EV hospitals and 11 other participating hospitals that did not report any HAIs.
In the EV, the diagnosis of urinary tract infections had a sensitivity of 72.0% and a specificity of 99.3%. The respective sensitivities of bloodstream infection and pneumonia were 63.2% and 70.6%; the respective specificities were 98.8% and 99.6%. The agreement (ĸ) between the EV and IV for 10 hospitals was 0.754 for urinary tract infections and 0.674 for bloodstream infections (P < .001, respectively). Additionally, IV found additional cases among 11 zero-report hospitals.
This study demonstrates the need for ongoing validation and continuous training to maintain the accuracy of nationwide surveillance data.
IV should be considered a validation method to supplement EV.
本研究分析了韩国国家医疗相关感染监测系统的医疗相关感染(HAI)数据的有效性。
验证过程包括外部(EV)和内部(IV)验证阶段。在2016年7月至2017年6月参与的193家医院中,对根据HAI率百分位数选择的10家医院进行了EV。EV团队审查了60例HAI患者和235例非HAI对照患者的295份病历。对10家EV医院和11家未报告任何HAI的其他参与医院进行了IV。
在EV中,尿路感染诊断的敏感性为72.0%,特异性为99.3%。血流感染和肺炎的敏感性分别为63.2%和70.6%;特异性分别为98.8%和99.6%。10家医院的EV和IV之间尿路感染的一致性(ĸ)为0.754,血流感染为0.674(P均<0.001)。此外,IV在11家零报告医院中发现了额外病例。
本研究表明需要持续进行验证和持续培训,以维持全国监测数据的准确性。
应将IV视为补充EV的一种验证方法。